Renin increments the inward calcium current in the failing heart

Walmor C De Mello1

  • 1Department of Pharmacology, Medical Sciences Campus, UPR, San Juan, Puerto Rico, USA. wmello@rcm.upr.edu

Insights

Renin and angiotensinogen increase calcium current in failing heart cells by forming angiotensin II. Renin internalization may also control this inward calcium current (ICa) in heart failure.

Area of Science:

  • Cardiovascular Physiology
  • Renal Physiology
  • Cellular Electrophysiology

Background:

  • The renin-angiotensin system (RAS) is implicated in cardiac remodeling.
  • The effect of renin on calcium currents in failing hearts remains unclear.

Purpose of the Study:

  • To investigate if renin influences the inward calcium current (ICa) in the failing heart.
  • To explore the mechanisms behind renin's effects on cardiac myocytes.

Main Methods:

  • Isolated cardiomyocytes from cardiomyopathic hamsters.
  • Patch-clamp technique to measure L-type ICa.
  • Application of renin, angiotensinogen, and inhibitors (enalapril, losartan).

Main Results:

  • Extracellular renin and angiotensinogen significantly increased peak ICa density.
  • This effect was blocked by enalapril and losartan, indicating angiotensin II involvement.
  • Intracellular renin and angiotensinogen also increased ICa, suggesting renin internalization.

Conclusions:

  • Extracellular renin increases ICa in failing heart myocytes via angiotensin II and AT1 receptors.
  • Intracellular renin administration also enhanced ICa, suggesting a role for renin internalization.
  • Renin internalization may play a role in regulating ICa in the failing heart.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...